Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

Ronald S. Go; Herbert C. Heien; Lindsey R. Sangaralingham; Elizabeth B. Habermann; Nilay D. Shah

doi:10.3324/haematol.2017.179978

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

Ronald S. Go, Herbert C. Heien, Lindsey R. Sangaralingham, Elizabeth B. Habermann, Nilay D. Shah

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	e123-e125
Journal	Haematologica
Volume	103
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2017.179978
State	Published - Feb 28 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2017.179978

Cite this

@article{56bf7c2febcb459dac2c561884b9098e,

title = "Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA",

author = "Go, {Ronald S.} and Heien, {Herbert C.} and Sangaralingham, {Lindsey R.} and Habermann, {Elizabeth B.} and Shah, {Nilay D.}",

note = "Funding Information: 1Division of Hematology and 2Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA Funding: this study was supported by research funding from the Mayo Clinic Division of Hematology to RSG, Mark A. and Elizabeth N. Binks Fund to RSG, and from the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to RSG. Correspondence: go.ronald@mayo.edu doi:10.3324/haematol.2017.179978 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.",

year = "2018",

month = feb,

day = "28",

doi = "10.3324/haematol.2017.179978",

language = "English (US)",

volume = "103",

pages = "e123--e125",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "3",

}

TY - JOUR

T1 - Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies

T2 - Determining demographic differences in the USA

AU - Go, Ronald S.

AU - Heien, Herbert C.

AU - Sangaralingham, Lindsey R.

AU - Habermann, Elizabeth B.

AU - Shah, Nilay D.

N1 - Funding Information: 1Division of Hematology and 2Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA Funding: this study was supported by research funding from the Mayo Clinic Division of Hematology to RSG, Mark A. and Elizabeth N. Binks Fund to RSG, and from the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery to RSG. Correspondence: go.ronald@mayo.edu doi:10.3324/haematol.2017.179978 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.

PY - 2018/2/28

Y1 - 2018/2/28

UR - http://www.scopus.com/inward/record.url?scp=85042754535&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042754535&partnerID=8YFLogxK

U2 - 10.3324/haematol.2017.179978

DO - 10.3324/haematol.2017.179978

M3 - Letter

C2 - 29269527

AN - SCOPUS:85042754535

SN - 0390-6078

VL - 103

SP - e123-e125

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: Determining demographic differences in the USA

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this